Stay updated on Semaglutide Dose Response Study in Type 2 Diabetes Clinical Trial
Sign up to get notified when there's something new on the Semaglutide Dose Response Study in Type 2 Diabetes Clinical Trial page.

Latest updates to the Semaglutide Dose Response Study in Type 2 Diabetes Clinical Trial page
- CheckyesterdayChange DetectedA notice about NIH’s transition from the term “Artificial Intelligence” to “Super Intelligence” appears at the top of the page.SummaryDifference0.7%

- Check8 days agoChange DetectedThe footer revision identifier changed from v3.7.1 to v3.7.2.SummaryDifference0.1%

- Check15 days agoChange DetectedThe ClinicalTrials.gov footer revision label changes from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check36 days agoChange DetectedA new revision label v3.7.0 was added to the study record history and the previous revision v3.6.6 was removed, reflecting an update to the page's revision history rather than substantive data changes.SummaryDifference0.1%

- Check57 days agoChange DetectedA new revision entry, v3.6.6, has been added to the record history. The previous v3.6.5 entry has been removed, updating the version list shown for the study record.SummaryDifference0.1%

- Check78 days agoChange DetectedA new revision entry for v3.6.5 has been added to the Study History, accompanying the record's latest version. The previous revision v3.6.4 is removed, indicating an update to the study record version in the history log.SummaryDifference0.1%

Stay in the know with updates to Semaglutide Dose Response Study in Type 2 Diabetes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Semaglutide Dose Response Study in Type 2 Diabetes Clinical Trial page.